Infinite Medical Spa · Research roundup

Cosmetic Procedure Statistics 2026: Botox, Fillers and the Most Common Treatments in Canada and the US

Plastic surgeons worldwide reported 37,951,364 aesthetic procedures in 2024, and the most performed one was botulinum toxin, with 7,887,955 treatments (ISAPS survey of 2,975 surgeons, published 2025). In the United States, neuromodulators were half of all minimally invasive treatments in 2025 (ASPS). Every figure below carries its source, population and year.

By the Infinite Medical Spa team, London, Ontario. Medical Director: Derek Truong, NP (Western University). First published 16 November 2026; last updated 16 November 2026. How to read these numbers · Sources

10 key cosmetic procedure statistics for 2026

  1. Plastic surgeons worldwide reported 37,951,364 aesthetic procedures in 2024: 17,415,678 surgical and 20,535,686 non-surgical, close to 38 million in total and 40% more than in 2020 (ISAPS Global Survey, 2,975 surgeons, performed 2024, published 2025). #
  2. Botulinum toxin was the most performed non-surgical procedure in the world in 2024, at 7,887,955 treatments, 17.4% fewer than surgeons reported for 2023 (ISAPS, 2024). #
  3. Hyaluronic acid filler was the second most performed non-surgical procedure worldwide in 2024, at 6,338,184 treatments, up 5.2% on 2023 (ISAPS, 2024). #
  4. In the United States, neuromodulator injections accounted for half of all minimally invasive aesthetic treatments performed in 2025, and hyaluronic acid fillers for another 30% (American Society of Plastic Surgeons, 2025 Procedural Statistics, more than 3,000 board-certified surgeons plus a national claims dataset). #
  5. Of hyaluronic acid filler treatments in the United States in 2025, 70% were for facial rejuvenation and 23% for lip augmentation (ASPS, 2025). #
  6. Botulinum toxin was the most common cosmetic procedure in every adult age band worldwide in 2024: 1,798,454 treatments at ages 18 to 34, 3,715,227 at 35 to 50, 1,861,557 at 51 to 64 and 473,277 at 65 and older (ISAPS, 2024). #
  7. Men had 1,265,482 of the world's 7,887,955 botulinum toxin treatments in 2024, about one in six (16%), and 879,517 of the 6,338,184 hyaluronic acid treatments (ISAPS, 2024; share computed from the survey's figures). #
  8. US cosmetic surgery reached 1,523,330 procedures in 2025, up 7% from 1,425,390 in 2024; liposuction (317,196) was the most performed operation for the fifth consecutive year and eyelid surgery (118,978, up 19%) the most performed facial surgery (ASPS, 2025). #
  9. The United States performed 4,165,645 non-surgical aesthetic procedures in 2024, 20.3% of the world total and more than any other country; Canada is not reported individually, and the same survey estimates 450 plastic surgeons in Canada, 0.8% of the 58,506 worldwide (ISAPS, 2024). #
  10. Botox Cosmetic earned AbbVie $669 million in global net revenues in the third quarter of 2026, up 4.9% on a reported basis, and $2.065 billion in the first nine months of the year, up 9.5% (AbbVie third-quarter results, 30 October 2026; revenues, not procedure counts). #

Each line is written to stand alone: who, how many, when and the publisher. Click # to link to a single statistic.

How to read these numbers

Three different populations appear on this page and they are never added together. The ISAPS Global Survey is surgeon-reported and extrapolated: 2,975 plastic surgeons in 2024, 32 locations reported individually, and the society notes that new procedures added to the form affect comparisons with earlier years. The ASPS figures are United States estimates built from member surgeons, a complications insurer's data and a national claims dataset, then extrapolated nationally; for 2025 ASPS published minimally invasive treatments as shares of volume, not counts. The Aesthetic Society's 2023 report covers surgical procedures only and uses a different dataset. Company revenues (AbbVie) and an association's industry estimate (AmSpa) are not procedure counts. Surveys report the previous calendar year, so "2024 data" was published in 2025. No Canadian body publishes a national procedure count; the Canadian section says what is known and what is not.

Cite or link to this page

Infinite Medical Spa. (2026). Cosmetic procedure statistics 2026: Botox, fillers and the most common treatments in Canada and the US. https://infinitemedicalspa.com/cosmetic-procedure-statistics/

Link to this page in HTML:

Please credit the original publisher as well: every figure above links to the society, journal or company that produced it.

How many cosmetic procedures are performed each year?

Worldwide, the ISAPS survey counted 37,951,364 aesthetic procedures in 2024 (17,415,678 surgical and 20,535,686 non-surgical), which the society rounds to "close to 38 million" and describes as a 40% increase since 2020. Non-surgical treatments outnumber operations by about one million worldwide and by more than two to one in the United States, where the survey recorded 4,165,645 non-surgical and 1,999,528 surgical procedures for 2024, a 6,165,173 total that is 16.2% of the world's. Brazil reported the most surgical procedures of any country, 2,354,513.

The US-only count from ASPS runs on a different basis and is published for surgery only: 1,523,330 cosmetic surgical procedures in 2025, 7% more than the 1,425,390 of 2024. The Aesthetic Society's dataset, which draws on a complications insurer, put US cosmetic surgery at 1,671,147 procedures in 2023, up 2.9% on 2022 and 10.2% on 2019. The two US figures differ because the datasets and years differ, not because one is wrong.

What are the most common cosmetic procedures?

Non-surgically, the same two treatments lead everywhere: botulinum toxin, then hyaluronic acid filler. Surgically, eyelid surgery overtook liposuction worldwide in 2024, while liposuction kept first place in the United States for a fifth year.

Most performed procedures, worldwide 2024 (ISAPS) and United States 2025 (ASPS). Change is against the previous year as each publisher reports it.
RankWorldwide non-surgical, 2024ProceduresUS cosmetic surgery, 2025Procedures
1Botulinum toxin (-17.4%)7,887,955Liposuction (-1%)317,196
2Hyaluronic acid filler (+5.2%)6,338,184Breast augmentation (+11%)304,234
3Hair removal (-12.9%)1,487,130Tummy tuck (+2%)173,251
4Non-surgical skin tightening (+38.9%)1,239,306Breast lift (+8%)156,131
5Chemical peel (+33.3%)820,225Eyelid surgery (+19%)118,978

Worldwide surgery in 2024 ranked eyelid surgery first at 2,115,360 (up 13.4%), then liposuction 2,087,189 (down 12.6%), breast augmentation 1,658,615 (down 17.5%), scar revision 1,156,446 and rhinoplasty 1,083,631 (down 9.8%). In the United States in 2025 the fastest-growing operations were facial fat grafting (34,117, up 39%), forehead lift (15,506, up 29%) and eyelid surgery (up 19%), while rhinoplasty fell 5% to 43,116 and facelifts rose 13% to 77,933. ASPS adds that 82% of its member surgeons received consultation requests related to GLP-1 weight-loss medications in 2025, a pattern it links to the growth in lift and contouring procedures.

Bar chart: the five most performed non-surgical aesthetic procedures worldwide in 2024. Botulinum toxin 7,887,955; hyaluronic acid filler 6,338,184; hair removal 1,487,130; non-surgical skin tightening 1,239,306; chemical peel 820,225. Source: ISAPS Global Survey 2024, 2,975 surgeons.
The five most performed non-surgical aesthetic procedures worldwide in 2024, as reported by 2,975 plastic surgeons to ISAPS. Chart: Infinite Medical Spa.
Embed this chart

<a href="https://infinitemedicalspa.com/cosmetic-procedure-statistics/#chart-top5"><img src="https://infinitemedicalspa.com/wp-content/uploads/2026/11/cosmetic-procedure-statistics-top-5-non-surgical-2024-wide.png" alt="Top 5 non-surgical aesthetic procedures worldwide in 2024 (ISAPS data), chart by Infinite Medical Spa" width="1600" height="900"></a>

How popular are Botox and other neuromodulators?

Botulinum toxin (sold as Botox, Dysport, Xeomin, Jeuveau, Letybo and Daxxify) was the world's most performed aesthetic procedure in 2024 with 7,887,955 treatments, and the most common cosmetic procedure in every adult age group: 1,798,454 at ages 18 to 34, 3,715,227 at 35 to 50 (about 47% of all botulinum toxin treatments), 1,861,557 at 51 to 64 and 473,277 at 65 and older. The one exception is under-18s, whose most common procedure was rhinoplasty (45,512). Women had 6,622,473 treatments and men 1,265,482, about one in six.

ISAPS recorded a 17.4% fall in botulinum toxin procedures between 2023 and 2024 while the United States still led every country with 4,165,645 non-surgical procedures. The society cautions that its broader 2024 sample and new form categories affect year-on-year comparisons, so the direction of that change should be read with its own caveat. In the United States, ASPS reports neuromodulators as half of all minimally invasive treatments performed in 2025, the largest category by volume, but it did not publish a count for 2025 while it looks for a data source that matches its surgical data.

Demand shows up in company accounts too: AbbVie's Botox Cosmetic brought in $669 million in the third quarter of 2026 ($388 million in the United States), up 4.9% on a reported basis, and $2.065 billion in the first nine months of 2026, up 9.5%. Those are revenues, not treatment counts, and they cover only one of the six products.

If you are weighing treatment yourself, the figures above describe what other people chose, not what suits you; the questions a nurse injector works through at a Botox consultation in London, Ontario start from your anatomy and goals, with the clinic's Medical Director, a Nurse Practitioner, on site.

How common are dermal and lip fillers?

Hyaluronic acid filler was the second most performed non-surgical procedure worldwide in 2024 at 6,338,184 treatments, up 5.2% on 2023, and the only one of the top two to grow. Including calcium hydroxyapatite (418,173) and poly-L-lactic acid (642,566) biostimulators, surgeons reported 15,286,878 injectable procedures of all kinds in 2024. Women had 5,458,666 hyaluronic acid treatments and men 879,517.

In the United States, hyaluronic acid fillers were 30% of minimally invasive treatments in 2025 (ASPS). Of those filler treatments, 70% were for facial rejuvenation and 23% for lip augmentation; for non-hyaluronic fillers the split was 80% face and 10% lips. Asked which facial rejuvenation approaches they used in 2025, ASPS member surgeons named hyaluronic acid fillers first (69%), then autologous fat grafting (49%), light or energy-based devices (45%), biostimulatory injectables (33%) and chemical peels (33%). AbbVie's Juvederm filler collection, by contrast, earned $222 million in the third quarter of 2026, down 11.9%, and $699 million over nine months.

What do Canadians have done? What the data says and does not say

No Canadian body publishes an annual count of cosmetic procedures. The Canadian Society of Plastic Surgeons has no statistics release on its website, Statistics Canada carries no series for aesthetic procedures, and the ISAPS survey does not report Canada among the 32 locations with their own procedure tables (Canada appears in that survey only in its medical-tourism lists of where patients travel from and to). What ISAPS does estimate is the number of plastic surgeons: 450 in Canada, 0.8% of the 58,506 worldwide and 26th in its ranking, against 7,752 in the United States. Treatment in Canada is also delivered by nurse injectors, dermatologists and other physicians who are outside a plastic-surgeon survey altogether, so a Canadian total would be larger than any surgeon-only count.

The practical reading for a Canadian patient is that the global and US pattern is the best available guide: botulinum toxin first, hyaluronic acid filler second, most treatments between ages 35 and 50, and men about one in six of botulinum toxin patients. This page will add a Canadian figure the day a Canadian body publishes one.

Who has cosmetic treatment? Age and sex

For non-surgical treatment the 35-to-50 age band dominates: 3,715,227 of the world's 7,887,955 botulinum toxin treatments in 2024. For US cosmetic surgery, ASPS reports that patients aged 36 to 55 had 738,000 of the nation's 1.5 million procedures in 2025, nearly half, with 36-to-45-year-olds the largest single group at about 386,500 procedures; the 56-to-65 group grew fastest, up 15%. The Aesthetic Society's 2023 surgical data gives a similar shape on its own base: 40.0% of procedures at ages 35 to 50, 27.7% at 51 to 64, 19.5% at 18 to 34, 11.9% at 65 and older and 0.9% at 17 and under; 64% of those operations took place in accredited surgical centres.

Women had 1,431,257 of the 1,523,330 US cosmetic surgery procedures in 2025, about 94% (ASPS). Worldwide, men's share is larger for non-surgical care: 1,265,482 botulinum toxin treatments (16%) and 879,517 hyaluronic acid treatments in 2024 (ISAPS).

How often do minimally invasive treatments cause adverse events?

The peer-reviewed evidence describes adverse-event rates from controlled trials, which is the right place to read them. A meta-analysis of 16 randomized, double-blind, placebo-controlled trials with 42,405 participants (Jia and colleagues, Aesthetic Plastic Surgery, 2016) found adverse events more frequent with botulinum toxin A than with placebo in facial rejuvenation overall (relative risk 1.24, 95% confidence interval 1.07 to 1.43). For frown-line treatment the increase was significant (RR 1.47), with headache (RR 1.53), eyelid ptosis (RR 5.56) and heavy eyelids (RR 6.94) the events that drove it; for crow's feet there was no significant increase overall, except injection-site hematoma (RR 2.14). The authors describe these as mild-to-moderate effects and conclude that injectors should follow established dosing and technique.

For hyaluronic acid facial fillers, a systematic review and meta-analysis of 19 randomized controlled trials (Colon and colleagues, Cureus, 2023) reports the adverse events as swelling, pain, redness, bruising, lumps and bumps, firmness, tenderness, itching and skin discolouration, with most mild and resolving over time, and notes that rare severe complications also occur. Both papers are reasons a consultation covers risks as well as results; neither gives a figure for any one clinic.

How big is the medical spa industry?

The American Med Spa Association describes a medical aesthetics industry that "has eclipsed $17 billion and is growing by more than $1 billion per year" (State of the Industry report page, 2026). That is an association estimate for the United States and the full report is available to its members; no equivalent Canadian figure is published. AbbVie's aesthetics portfolio, the largest single supplier's view of the same market, had $1.176 billion in global net revenues in the third quarter of 2026, down 1.4%, with Botox Cosmetic growing and Juvederm declining.

What this means if you are considering treatment

Three things follow from the numbers. First, the most common treatments are the minimally invasive ones, and botulinum toxin and hyaluronic acid filler account for most of them, so the questions to ask a clinic are about those two before anything else. Second, the typical patient is between 35 and 50 and most patients are women, but men are a sixth of botulinum toxin patients worldwide and the over-55s are the fastest-growing surgical group in the United States, so there is no age or sex for which treatment is unusual. Third, the trial evidence on adverse events is specific: headaches, eyelid heaviness and bruising are the documented effects for neuromodulators, swelling and lumps for fillers, and they are the things to discuss at a consultation. At Infinite Medical Spa, injectable treatments are performed by nurse injectors with the clinic's Medical Director, a Nurse Practitioner, on site, and every new patient starts with a consultation.

Infinite Medical Spa, London, Ontario

Want to know what these numbers mean for you? It starts with a consultation.

A nurse injector assesses your anatomy and goals and recommends a plan, with the clinic's Medical Director, Derek Truong, NP, on site. You leave knowing what we would recommend and why, with no obligation to book treatment.

551 Oxford St W, Unit 201 · (519) 709-6494 · Mon to Sat, 8 to 4

Frequently asked questions

How many cosmetic procedures are performed each year worldwide?

About 38 million. The ISAPS survey of 2,975 plastic surgeons recorded 37,951,364 aesthetic procedures in 2024: 17,415,678 surgical and 20,535,686 non-surgical, a 40% increase since 2020 (ISAPS, published 2025).

What is the most common cosmetic procedure?

Botulinum toxin injection. It was the most performed non-surgical procedure worldwide in 2024 with 7,887,955 treatments (ISAPS), and in the United States neuromodulators were half of all minimally invasive treatments in 2025 (ASPS). The most common operation was eyelid surgery worldwide (2,115,360) and liposuction in the United States (317,196).

How many people get Botox each year?

Surgeons reported 7,887,955 botulinum toxin procedures worldwide in 2024 (ISAPS). That is a count of treatments performed by plastic surgeons, extrapolated from 2,975 respondents, not of people; it excludes treatments by nurse injectors, dermatologists and other physicians, so the number of people treated is higher.

What is the average age for Botox?

No source publishes an average age. The largest band is 35 to 50, which accounted for 3,715,227 of the 7,887,955 botulinum toxin treatments worldwide in 2024, about 47%; 18 to 34 had 1,798,454, 51 to 64 had 1,861,557 and 65 and older had 473,277 (ISAPS, 2024).

Are there cosmetic procedure statistics for Canada?

Not as a national count. No Canadian body publishes one and the ISAPS survey does not report Canada's procedures individually; it estimates 450 plastic surgeons in Canada, 0.8% of the world's 58,506 (ISAPS, 2024). The global and US patterns are the best available guide.

Sources, disclosures and corrections

  1. International Society of Aesthetic Plastic Surgery. ISAPS International Survey on Aesthetic/Cosmetic Procedures performed in 2024 (PDF) and the press release of 19 June 2025. Pages 4, 6, 7, 51, 59 and 60.
  2. American Society of Plastic Surgeons. 2025 Procedural Statistics Release (PDF). Pages 6 to 9, 13, 14, 28 to 30, 38 and 40.
  3. The Aesthetic Society, in collaboration with CosmetAssure. Aesthetic Plastic Surgery Statistics 2023 (PDF). Pages 9, 10, 14 and 17.
  4. American Med Spa Association. Medical Spa State of the Industry Report (summary page, 2026).
  5. Jia Z, Lu H, Yang X, et al. Adverse Events of Botulinum Toxin Type A in Facial Rejuvenation: A Systematic Review and Meta-Analysis. Aesthetic Plastic Surgery. 2016;40(5):769-777. doi:10.1007/s00266-016-0682-1
  6. Colon J, Mirkin S, Hardigan P, Elias MJ, Jacobs RJ. Adverse Events Reported From Hyaluronic Acid Dermal Filler Injections to the Facial Region: A Systematic Review and Meta-Analysis. Cureus. 2023;15(4):e38286. doi:10.7759/cureus.38286
  7. AbbVie. AbbVie Reports Third-Quarter 2026 Financial Results, 30 October 2026.

How this page was made. Every figure was read in its source document and recorded in a source log with the source's wording and the date read; the ten key statistics are checked by a person before each edition. AI tools helped collect and organise the figures; the sources, selection and wording are the clinic's responsibility. Commercial interest: Infinite Medical Spa provides neuromodulator, filler, laser and skin treatments in London, Ontario; the figures on this page are the publishers' own, and no publisher cited here paid for or reviewed this page. Corrections: spotted an error? Email the clinic through the contact page; corrections are dated at the foot of this page. Corrections log: none yet.

Stay up to date with the latest news, promotions, and offers from Infinite Medical Spa. Sign up for our newsletter today and never miss an update.